Scarica l'app Stockscreener
22.96
5.13%
1.12
Dopo l'orario di chiusura:
23.37
0.41
+1.79%
Arcus Biosciences Inc Borsa (RCUS) Ultime notizie
RCUS Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Arcus Biosciences, Inc. (RCUS) Stock forecasts - Yahoo Finance UK
Arcus Biosciences (NYSE:RCUS) Trading 5.4% Higher Following Analyst Upgrade - MarketBeat
RCUS: Wedbush Raises Price Target for Arcus Biosciences | RCUS S - GuruFocus
Arcus Biosciences (NYSE:RCUS) Price Target Raised to $41.00 - MarketBeat
RCUS Technical Analysis & Stock Price Forecast - Intellectia AI
Gainers Report: Will Arcus Biosciences Inc stock benefit from M A2026 Breakouts & Risk Controlled Stock Pick Alerts - baoquankhu1.vn
Arcus Biosciences, Inc. (RCUS) Stock Forecasts - Yahoo Finance
Behavioral Patterns of RCUS and Institutional Flows - Stock Traders Daily
Insider Trends: Is Arcus Biosciences Inc still a buy after recent gains2026 Retail Activity & Real-Time Volume Analysis Alerts - baoquankhu1.vn
RCUS Price History for Arcus Biosciences Stock - Barchart.com
Arcus Biosciences (RCUS) Vanguard shows 0 shares after Jan 12, 2026 realignment - Stock Titan
Arcus Biosciences (NYSE:RCUS) Upgraded at Truist Financial - MarketBeat
Arcus Biosciences, Inc. (NYSE:RCUS) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Arcus Executives Offload Shares Amid Surge in Hiring—A "Pump and Dump" Warning Sign for RCUS - Bitget
Two new hires get Arcus stock awards priced at $21.41 a share - Stock Titan
Gilead Sciences Inc and Arcus Biosciences Inc Post ARC-7 Plenary Q&A Transcript - GuruFocus
Arcus Biosciences, Inc. Files Form 8-K with SEC for Common Stock Listed on NYSE (RCUS) - Minichart
Arcus Biosciences, Inc. Announces Resignation of Jennifer Jarrett as Chief Operating Officer, Effective March 30, 2026 - marketscreener.com
Arcus Biosciences Announces COO Resignation and Transition Plan - TipRanks
Arcus Biosciences chief operating officer Jennifer Jarrett to resign March 30 - Investing.com Australia
Arcus Biosciences' Jennifer Jarrett to Resign as COO, Effective March 30, 2026 - TradingView
Arcus Biosciences chief operating officer Jennifer Jarrett to resign March 30 By Investing.com - Investing.com South Africa
Arcus Biosciences COO Jennifer Jarrett to resign March 30 - StreetInsider
COO Jennifer Jarrett to exit Arcus Biosciences (RCUS), stay on as advisor - Stock Titan
Aug Setups: Can Arcus Biosciences Inc stock double in the next year2026 Earnings & Real-Time Buy Signal Alerts - baoquankhu1.vn
Hudson Bay Capital Management LP Has $4.62 Million Stake in Arcus Biosciences, Inc. $RCUS - MarketBeat
RCUS PE Ratio & Valuation, Is RCUS Overvalued - Intellectia AI
(RCUS) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
Arcus Biosciences, Inc. (RCUS) Stock Price History & Data - Traders Union
B of A Securities Maintains Arcus Biosciences (RCUS) Neutral Recommendation - MSN
Arcus Biosciences, Inc. $RCUS Shares Bought by Decheng Capital LLC - MarketBeat
Here’s what analysts think about Arcus Biosciences (RCUS) - MSN
WINTON GROUP Ltd Purchases Shares of 92,229 Arcus Biosciences, Inc. $RCUS - MarketBeat
Why Arcus Biosciences (RCUS) Is Up 9.5% After New Casdatifan Data And Pipeline Expansion - simplywall.st
Arcus Biosciences (RCUS) Valuation After Casdatifan Kidney Cancer Data Pipeline Update And Earnings - Sahm
How (RCUS) Movements Inform Risk Allocation Models - Stock Traders Daily
New Arcus Biosciences hires receive stock options at $23.43 - Stock Titan
Arcus Biosciences at Leerink Conference: Casdatifan’s Promising Data By Investing.com - Investing.com Canada
RCUS: Casdatifan delivers higher efficacy and durable responses in RCC, with strong upcoming trial data - TradingView
Is Arcus Biosciences Inc still a buy after recent gainsWeekly Trading Summary & Comprehensive Market Scan Insights - baoquankhu1.vn
Performance Recap: Can Arcus Biosciences Inc disrupt its industryJuly 2025 Macro Moves & Scalable Portfolio Growth Methods - baoquankhu1.vn
Vanguard Group Inc. Increases Stock Holdings in Arcus Biosciences, Inc. $RCUS - MarketBeat
Aug Sectors: Is Arcus Biosciences Inc in a long term uptrendQuarterly Performance Summary & Free High Return Stock Watch Alerts - baoquankhu1.vn
Citigroup Raises Arcus Biosciences (RCUS) Price Target to $45 | - GuruFocus
Citigroup Raises Arcus Biosciences (NYSE:RCUS) Price Target to $45.00 - MarketBeat
Fisher Asset Management LLC Acquires 640,990 Shares of Arcus Biosciences, Inc. $RCUS - MarketBeat
RCUS SEC FilingsArcus Bioscience 10-K, 10-Q, 8-K Forms - Stock Titan
Arcus (RCUS) Q4 2025 Earnings Call Transcript - AOL.com
RCUS Stock Jumps 17.5% Despite $353M Net Loss: What $34 Fair Value Signals - TIKR.com
Arcus Biosciences (RCUS) Is Up 27.0% After Casdatifan Kidney Cancer Data And TKI-Free Strategy Shift - simplywall.st
The Analyst Verdict: Arcus Biosciences In The Eyes Of 5 Experts - Sahm
Arcus Biosciences: Q4 Beat And Casdatifan’s Story So Far (NYSE:RCUS) - Seeking Alpha
RCUS Analyst Rating Updated by Leerink Partners | RCUS Stock New - GuruFocus
0.49%
1.47%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):